Clinical trials Our clinical trials ADVANCE SC+ (Thrombocytopenia - RECRUITMENT: CLOSED) Project Title A Phase 3 Study to evaluate the safety and efficacy of Efgartigimod PH20 subcutaneous in adult patients with primary immune thrombocytopenia (ADVANCE SC+) Official Title A Phase 3, Multicenter, Open-Label, Long-Term Trial to evaluate the safety and efficacy of Efgartigimod (ARGX-113) PH20 subcutaneous in adult patients with primary immune thrombocytopenia Project Summary A Phase 3 study to evaluate the safety and efficacy of efgartigimod PH20 subcutaneous in adult patients with primary immune thrombocytopenia Blood Disorder Primary immune thrombocytopenia Patient Recruitment Details Patient recruitment status: closed Number of patients (Globally) Undetermined.